Bitnomial launches Injective futures in US, with eyes on ETF eligibility
Burns Brief
The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital Market sentiment is turning positive, with traders and analysts pointing to potential follow-through momentum in the coming sessions. Watch for volume confirmation — a breakout above average volume would signal the trend is likely to continue.
The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital.
Key Takeaways
- The contracts mark Injective’s first entry into US-regulated derivatives markets and could help support a spot ETF following a filing from Canary Capital